PODD vs SAM · P/E 34, rev $2.07B vs rev $2.01B
Insulet Corporation (PODD) versus Boston Beer Company Inc (SAM) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. SAM currently screens at market cap $1.79B.
Not investment advice. Open the PODD and SAM stock pages for the full models.
Not investment advice.